Will AI replace MedX?MedX has stated in their presentations that they think AI as a decision outcome tool is dangerous. That is why they have focused in having Dermatologists access any moles or lesions.That way the company is never at risk of falsely analysing a patient ofa non-melanoma only to find out the AI was wrong and the patient did in fact have a deadly melanoma.Mutiple lawsuits and a failed business model.
The biggest issue for the acceptance of teledermatology is high quality images (42%) failure rate currently) MedX's AI guarantees all images will be readable by dermatologists because of their image quality. that is how they explained part of their AI strategy in the presentation.
Recent research seems to support this;
https://ecancer.org/en/news/21035-direct-to-consumer-skin-cancer-detection-apps-are-failing-to-detect-life-threatening-cancers-new-study-finds